Hematopoietic stem cell aging and leukemia transformation

Blood. 2023 Aug 10;142(6):533-542. doi: 10.1182/blood.2022017933.

Abstract

With aging, hematopoietic stem cells (HSCs) have an impaired ability to regenerate, differentiate, and produce an entire repertoire of mature blood and immune cells. Owing to dysfunctional hematopoiesis, the incidence of hematologic malignancies increases among elderly individuals. Here, we provide an update on HSC-intrinsic and -extrinsic factors and processes that were recently discovered to contribute to the functional decline of HSCs during aging. In addition, we discuss the targets and timing of intervention approaches to maintain HSC function during aging and the extent to which these same targets may prevent or delay transformation to hematologic malignancies.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aging
  • Cellular Senescence
  • Hematologic Neoplasms* / therapy
  • Hematopoiesis / physiology
  • Hematopoietic Stem Cells / physiology
  • Humans
  • Leukemia* / therapy